💊 Drugs Class I - Dangerous
Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib
All Recalls
95,083 total recalls in our database
💊 Drugs Class I - Dangerous
Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib
💊 Drugs Class I - Dangerous
Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib
💊 Drugs Class I - Dangerous
Superpotent Drug: An oversized tablet was found in a bottle.
💊 Drugs Class I - Dangerous
Presence of Particulate Matter
Fluphenazine Decanoate Injection, USP; 25 mg/mL, 5mL vials, Rx only, APP Pharmaceuticals, LLC Schaumburg, IL 60173, NDC 63323-0272-05
Fresenius Kabi USA
💊 Drugs Class I - Dangerous
Subpotent Drug
💊 Drugs Class I - Dangerous
Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib
Vancomycin HCl 750 mg added to 5% Dextrose 250 mL For IV Use Only, Rx Only, SCA Pharmaceuticals, Little Rock, AR 72205, NDC 70004-0918-40
SCA Pharmaceuticals
💊 Drugs Class I - Dangerous
Presence of particulate matter - this recall is due to a recent Hospira recall of vancomyicn hydrochloride 10gm vials due to presence of particulate matter.
RIVASTIGMINE Tartrate Capsules, USP, 1.5 mg, 60-count bottle, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachupally 500-900 India, NDC 55111-352-60
Dr. Reddy's Laboratories
💊 Drugs Class I - Dangerous
Cross-contamination with other products -Related Substances test for Rivastigmine Tartrate Capsules USP, 1.5 mg showed a peak for Ranitidine.
💊 Drugs Class I - Dangerous
Marketed without an Approved NDA/ANDA: Product contains N-desmethyl tadalafil an analogue to tadalafil which is an active pharmaceutical ingredient in a FDA approved drug used to treat erectile dysfunction (ED).
Vancomycin Hydrochloride for Injection, USP, 10 grams, Pharmacy Bulk Package - Not For Direct Infusion, For Intravenous Use, packaged in 100 mL glass vial, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-6510-01
Hospira Inc., A Pfizer Company
💊 Drugs Class I - Dangerous
Presence of Particulate Matter: A hair was found stuck to the stopper of inside a single vial. The hair came in contact with the reconstituted drug product.
💊 Drugs Class I - Dangerous
Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib
Quinapril Tablets USP 5 mg, 90 count bottles, Lupin Pharmaceuticals, Inc., Baltimore, MD --- NDC 68180-556-09
Lupin Pharmaceuticals
💊 Drugs Class I - Dangerous
Failed Impurities/Degradation Specifications; Impurity A
Vancomycin HCl 1 g added to 0.9% Sodium Chloride 250 mL Bag For IV Use Only, Rx Only, SCA Pharmaceuticals, Little Rock, AR 72205, NDC 70004-0920-59
SCA Pharmaceuticals
💊 Drugs Class I - Dangerous
Presence of particulate matter - this recall is due to a recent Hospira recall of vancomyicn hydrochloride 10gm vials due to presence of particulate matter.
Vancomycin HCl 1.5 gram added to 5% Dextrose 500 mL Total Approximate Volume 515 mL For IV Use Only, Rx Only , SCA Pharmaceuticals, Little Rock, AR 72205, NDC 70004-0925-44
SCA Pharmaceuticals
💊 Drugs Class I - Dangerous
Presence of particulate matter - this recall is due to a recent Hospira recall of vancomyicn hydrochloride 10gm vials due to presence of particulate matter.
Vancomycin HCl 1.25 g added to 5% Dextrose 250 mL Bag For IV Use Only, Rx Only, SCA Pharmaceuticals, Little Rock, AR 72205, NDC 70004-0922-40
SCA Pharmaceuticals
💊 Drugs Class I - Dangerous
Presence of particulate matter - this recall is due to a recent Hospira recall of vancomyicn hydrochloride 10gm vials due to presence of particulate matter.
💊 Drugs Class I - Dangerous
Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib
💊 Drugs Class I - Dangerous
Labeling: Incorrect or Missing Package Insert: product lots packaged with an out-of-date insert.
🏥 Medical Devices Class I - Dangerous
Product sterility is compromised due to breach of sterile barrier
Potential for the ADVIA Centaur Syphilis assay to interfere with the BR (CA 27.29) a assay on the ADVIA Centaur Systems